Skip to Content
Merck
CN

H6508

Heparin−Agarose

Type I, saline suspension

Synonym(s):

Heparin beads, Heparin resin

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

UNSPSC Code:
23151817
NACRES:
NA.56
MDL number:
MFCD00163876

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

heparin from Porcine intestinal mucosa

type

Type I

form

saline suspension

extent of labeling

400-1500 μg per mL packed gel (activity approx. 140 USP units per mg)

technique(s)

affinity chromatography: suitable

matrix

cross-linked 4% beaded agarose

matrix activation

cyanogen bromide

matrix attachment

amino

matrix spacer

1 atom

suitability

suitable for chromatography

storage temp.

2-8°C

Quality Level

200

Looking for similar products? Visit Product Comparison Guide

Application

Heparin-agarose is developed from porcine intestinal mucosa and is used in affinity chromatography. Heparin-agarose has been used in studies to provide information on human monocytic ehrlichiosis, tumor necrosis and the effects of coagulation from Vipera snake venom.

Physical form

Suspension in 0.5 M NaCl containing preservative

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000512104
0000512104
0000477200
0000477200
0000368331

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Analysis of Adeno-Associated Virus and HPV Interaction.
Hermonat, P.L., et al.
Methods in Molecular Medicine, 119, 397-409 (2006)
91. Universal purification of AAV serotypes 1?5 modified to contain a heparin binding epitope.
Faust, S.M., et al.
Molecular Therapy, 9, S36-S36 (2004)
I V Kaplan et al.
Atherosclerosis, 158(2), 455-463 (2001-10-05)
Oxidation of beta-lipoproteins has been linked to the development of arteriosclerosis. Using a copper mediated cell free system to oxidize beta-lipoproteins, we found that beta -lipoproteins isolated from plasma were less susceptible to oxidation than lipoproteins from serum and that
M E Silvestri et al.
Scandinavian journal of immunology, 53(3), 282-289 (2001-03-17)
An investigation was performed into the heparin-binding properties of a synthetic peptide deduced from the sequence of human cytomegalovirus glycoprotein B. The peptide, T7-13:3, amino acids 69-78, which was previously shown to contain a neutralization epitope was able to bind
Janice Nickells et al.
Journal of virology, 82(24), 12510-12519 (2008-10-10)
A molecular clone of yellow fever virus (YFV) strain 17D was used to identify critical determinants of mouse neuroinvasiveness previously localized to domain III of the neuroadapted SPYF-MN virus envelope protein. Three candidate virulence substitutions (305F-->V, 326K-->E, and 380R-->T) were
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service